NCT07372378
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
- Locations
-
Not specified
Clinical trial condition
Carcinoma, Non-Small-Cell Lung
Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.
4,696 public trials
1,038 recruiting studies
Carcinoma, Non-Small-Cell Lung trial results
Not Yet Recruiting
Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study
NCT07365410
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
Not Yet Recruiting
Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
NCT07361484
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI
NCT07355231
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
Not specified
Not Yet Recruiting
First in Human Study of QLS5316 in Solid Tumors
NCT07358884
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +29 more
- Locations
-
Not specified
Not Yet Recruiting
Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With Firmonertinib 80 mg
NCT07298148
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified
Not Yet Recruiting
Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer
NCT07351565
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC
NCT07353476
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk
NCT07347977
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- The first affiliated hospital of Ningbo University Ningbo, Zhejiang, China
Not Yet Recruiting
Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases
NCT07343479
- Conditions
- Brain Diseases, Brain Metastasis, Brain Neoplasms, +16 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China